Source comparison
BPC-157 Long COVID Brain Fog: Treatment Protocol Comparison
Dose 250 mcg subcutaneous once daily 250–500 mcg subcutaneous twice daily (AM/PM) Animal vascular repair models show sustained VEGF upregulation requires repeated dosing; single daily dose may not maintain signaling threshold Duration 4–6 weeks Minimum 8–12 we
This comparison does not assign a generated winner or score.
- Dose
- 250 mcg subcutaneous once daily
- 250–500 mcg subcutaneous twice daily (AM/PM)
- Animal vascular repair models show sustained VEGF upregulation requires repeated dosing; single daily dose may not maintain signaling threshold
- Duration
- 4–6 weeks
- Minimum 8–12 weeks
- Endothelial repair and angiogenesis occur over weeks to months; symptom improvement in post-viral syndromes follows tissue-level changes, not acute signaling
- Injection Site
- Abdominal subcutaneous tissue
- Rotate between abdomen, thigh, upper arm
- Reduces localized irritation and ensures consistent absorption across adipose tissue sites
- Adjunct Support
- None specified
- Omega-3 (2–3g EPA/DHA daily) + Vitamin D (4000–5000 IU if deficient)
- Omega-3 supports endothelial function and reduces systemic inflammation; Vitamin D deficiency is common in long COVID and impairs vascular repair
- Monitoring
- Subjective symptom tracking
- Objective cognitive testing (Montreal Cognitive Assessment or equivalent) at baseline, 4 weeks, 8 weeks
- Subjective improvement can reflect placebo effect; validated cognitive tools quantify working memory, processing speed, executive function changes
- Bottom Line
- Minimally effective without adjunct strategies and extended duration
- Extended duration with objective monitoring and vascular support significantly improves likelihood of measurable cognitive improvement